BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 20, 2026
See today's BioWorld
Home
» All is loss for P53 mutations, study argues
To read the full story,
subscribe
or
sign in
.
All is loss for P53 mutations, study argues
Sep. 1, 2021
By
Anette Breindl
More than half of cancers have mutations in the transcription factor p53, making p53 one of the most frequently mutated genes in solid tumors.
BioWorld
Science
Cancer